skip to main content

Title: Science@SLAC—Discovering New Drugs

SLAC scientists and private-sector drug makers describe how a public--private partnership combined with the specialized X-rays from the Stanford Synchrotron Radiation Lightsource (SSRL) enable smart drug design that eliminates the costly trial-and-error approach used by traditional drug companies. SSRL is a synchrotron lightsource laboratory used by scientists from a range of disciplines to study matter on the scale of atoms and molecules. Featured in this video are SLAC Laboratory Director Persis Drell, SSRL staff scientist Clyde Smith, and Dave Bushnell, a scientist from startup drug maker Cocrystal Discovery Inc.
Authors:
; ;
Publication Date:
OSTI Identifier:
1248478
Resource Type:
Multimedia
Research Org:
SLAC (SLAC National Accelerator Laboratory (SLAC), Menlo Park, CA (United States))
Sponsoring Org:
USDOE
Country of Publication:
United States
Language:
English
Subject:
99 GENERAL AND MISCELLANEOUS; X-RAYS; STANFORD SYNCHROTRON RADIATION LIGHTSOURCE; SSRL; DRUGS; ATOMS; MOLECULES